Comparison of the genotypic and phenotypic properties of HIV-1 standard subtype B and subtype B/B′ env molecular clones derived from infections in China

Hui XieGraduate School of Peking Union Medical College No. 9 Dongdan Santiao 100730BeijingDongcheng District,China;Division of HIV/AIDS and Sexually Transmitted Virus VaccinesNational Institutes for Food and Drug Control (NIFDC) No. 31 Huatuo Street 102629BeijingDaxing District,China

Jianhui NieDivision of HIV/AIDS and Sexually Transmitted Virus VaccinesNational Institutes for Food and Drug Control (NIFDC) No. 31 Huatuo Street 102629BeijingDaxing District,China

Qingqing ChenDivision of HIV/AIDS and Sexually Transmitted Virus VaccinesNational Institutes for Food and Drug Control (NIFDC) No. 31 Huatuo Street 102629BeijingDaxing District,China

Weijin HuangDivision of HIV/AIDS and Sexually Transmitted Virus VaccinesNational Institutes for Food and Drug Control (NIFDC) No. 31 Huatuo Street 102629BeijingDaxing District,China

Youchun WangGraduate School of Peking Union Medical College No. 9 Dongdan Santiao 100730BeijingDongcheng District,China;Division of HIV/AIDS and Sexually Transmitted Virus VaccinesNational Institutes for Food and Drug Control (NIFDC) No. 31 Huatuo Street 102629BeijingDaxing District,ChinaCorrespondence[email protected]

Pages 1-13 | Received 28 Nov 2017, Accepted 13 Apr 2018, Published online: 16 May 2018

Cite this article
https://doi.org/10.1038/s41426-018-0087-0
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

PlotkinSAVaccines: correlates of vaccine-induced immunityClin. Infect. Dis.200847 401 40910.1086/589862
PubMed Web of Science ®Google Scholar
FerrantelliFComplete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodiesJ. Infect. Dis.20041892167217310.1086/420833
PubMed Web of Science ®Google Scholar
ShingaiMPassive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaquesJ. Exp. Med.20142112061207410.1084/jem.201324944172223
PubMed Web of Science ®Google Scholar
HuangYEngineered bispecific antibodies with exquisite HIV-1-neutralizing activityCell20161651621163110.1016/j.cell.2016.05.0244972332
PubMed Web of Science ®Google Scholar
Rerks-NgarmSVaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in ThailandN. Engl. J. Med.20093612209222010.1056/NEJMoa0908492
PubMed Web of Science ®Google Scholar
MontefioriDCMagnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trialsJ. Infect. Dis.201220643144110.1093/infdis/jis3673392187
PubMed Web of Science ®Google Scholar
WalkerLMBroad neutralization coverage of HIV by multiple highly potent antibodiesNature201147746647010.1038/nature103733393110
PubMed Web of Science ®Google Scholar
WalkerLMBroad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine targetScience200932628528910.1126/science.11787463335270
PubMed Web of Science ®Google Scholar
StamatatosLMorrisLBurtonDRMascolaJRNeutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?Nat. Med.20091586687010.1038/nm.1949
PubMed Web of Science ®Google Scholar
PatilSConformational epitope-specific broadly neutralizing plasma antibodies obtained from an HIV-1 clade C-infected elite neutralizer mediate autologous virus escape through mutations in the V1 LoopJ. Virol.2016903446345710.1128/JVI.03090-154794693
PubMed Web of Science ®Google Scholar
FenyoEMInternational network for comparison of HIV neutralization assays: the NeutNet reportPLoS ONE20094e450510.1371/journal.pone.00045052640999
PubMed Web of Science ®Google Scholar
MascolaJRRecommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccinesJ. Virol.200579101031010710.1128/JVI.79.16.10103-10107.20051182642
PubMed Web of Science ®Google Scholar
MontefioriDCMeasuring HIV neutralization in a luciferase reporter gene assayMethods Mol. Biol.200948539540510.1007/978-1-59745-170-3_26
PubMedGoogle Scholar
PolonisVRRecent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccinationVirology200837531532010.1016/j.virol.2008.02.007
PubMed Web of Science ®Google Scholar
HeyndrickxLInternational network for comparison of HIV neutralization assays: the NeutNet report IIPLoS ONE20127e3643810.1371/journal.pone.00364383348930
PubMed Web of Science ®Google Scholar
NieJOptimization and proficiency testing of a pseudovirus-based assay for detection of HIV-1 neutralizing antibody in ChinaJ. Virol. Methods201218526727510.1016/j.jviromet.2012.07.011
PubMed Web of Science ®Google Scholar
McLindenRJDetection of HIV-1 neutralizing antibodies in a human CD4(+)/CXCR4(+)/CCR5(+) T-lymphoblastoid cell assay systemPLoS ONE20138e7775610.1371/journal.pone.00777563842913
PubMed Web of Science ®Google Scholar
Sarzotti-KelsoeMOptimization and validation of a neutralizing antibody assay for HIV-1 in A3R5 cellsJ. Immunol. Methods201440914716010.1016/j.jim.2014.02.0134138262
PubMed Web of Science ®Google Scholar
Sarzotti-KelsoeMOptimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1J. Immunol. Methods201440913114610.1016/j.jim.2013.11.022
PubMed Web of Science ®Google Scholar
LiMHuman immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodiesJ. Virol.200579101081012510.1128/JVI.79.16.10108-10125.20051182643
PubMed Web of Science ®Google Scholar
OzakiDAInternational technology transfer of a GCLP-compliant HIV-1 neutralizing antibody assay for human clinical trialsPLoS ONE20127e3096310.1371/journal.pone.00309633267749
PubMed Web of Science ®Google Scholar
ChongHGenetic and neutralization properties of HIV-1 env clones from subtype B/BC/AE infections in ChinaJ. Acquir. Immune Defic. Syndr.20084753554310.1097/QAI.0b013e3181663967
PubMed Web of Science ®Google Scholar
NieJGenotypic and phenotypic characterization of HIV-1 CRF01_AE env molecular clones from infections in ChinaJ. Acquir. Immune Defic. Syndr.20105344045010.1097/QAI.0b013e3181cb8300
PubMed Web of Science ®Google Scholar
ShangHGenetic and neutralization sensitivity of diverse HIV-1 env clones from chronically infected patients in ChinaJ. Biol. Chem.2011286145311454110.1074/jbc.M111.2245273077651
PubMed Web of Science ®Google Scholar
WangSNieJWangYComparisons of the genetic and neutralization properties of HIV-1 subtype C and CRF07/08_BC env molecular clones isolated from infections in ChinaVirus Res.201115513714610.1016/j.virusres.2010.09.012
PubMed Web of Science ®Google Scholar
JunqueiraDMAlmeidaSEHIV-1 subtype B: traces of a pandemicVirology201649517318410.1016/j.virol.2016.05.00327228177
PubMed Web of Science ®Google Scholar
DengXLiuHShaoYRaynerSYangRThe epidemic origin and molecular properties of B’: a founder strain of the HIV-1 transmission in AsiaAIDS2008221851185810.1097/QAD.0b013e32830f4c62
PubMed Web of Science ®Google Scholar
HeXA comprehensive mapping of HIV-1 genotypes in various risk groups and regions across China based on a nationwide molecular epidemiologic surveyPLoS ONE20127e4728910.1371/journal.pone.00472893466245
PubMed Web of Science ®Google Scholar
LiLHIV-1 Thai B strain has spread out of former plasma donors into general population through sexual contact in Henan, ChinaJ. Med. Virol.20168861462110.1002/jmv.24383
PubMed Web of Science ®Google Scholar
HwangSSBoyleTJLyerlyHKCullenBRIdentification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1Science1991253717410.1126/science.1905842
PubMed Web of Science ®Google Scholar
Santoro-LopesGHIV disease progression and V3 serotypes in Brazil: is B different from B-Br?AIDS Res. Hum. Retrovir.20001695395810.1089/08892220050058362
PubMed Web of Science ®Google Scholar
LealEVillanovaFEDiversity of HIV-1 subtype B: implications to the origin of BF recombinantsPLoS ONE20105e1183310.1371/journal.pone.00118332911370
PubMed Web of Science ®Google Scholar
KwongPDMascolaJRHuman antibodies that neutralize HIV-1: identification, structures, and B cell ontogeniesImmunity20123741242510.1016/j.immuni.2012.08.0124706166
PubMed Web of Science ®Google Scholar
ScanlanCNThe broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1–2 mannose residues on the outer face of gp120J. Virol.2002767306732110.1128/JVI.76.14.7306-7321.2002136327
PubMed Web of Science ®Google Scholar
BinleyJMComprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodiesJ. Virol.200478132321325210.1128/JVI.78.23.13232-13252.2004524984
PubMed Web of Science ®Google Scholar
LealESilvaWPSucupiraMCJaniniLMDiazRSMolecular and structural characterization of HIV-1 subtype B Brazilian isolates with GWGR tetramer at the tip of the V3-loopVirology200838122222910.1016/j.virol.2008.08.029
PubMed Web of Science ®Google Scholar
de BritoAWomen infected with HIV type 1 Brazilian variant, subtype B (B′-GWGR motif) have slower progression to AIDS, compared with patients infected with subtype B (B-GPGR motif)Clin. Infect. Dis.2006431476148110.1086/508875
PubMed Web of Science ®Google Scholar
deCampAGlobal panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodiesJ. Virol.2014882489250710.1128/JVI.02853-133958090
PubMed Web of Science ®Google Scholar
McCoyLEBurtonDRIdentification and specificity of broadly neutralizing antibodies against HIVImmunol. Rev.2017275112010.1111/imr.124845299474
PubMed Web of Science ®Google Scholar
BurtonDRA large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individualsProc. Natl. Acad. Sci. USA199188101341013710.1073/pnas.88.22.1013452882
PubMed Web of Science ®Google Scholar
WuXRational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1Science201032985686110.1126/science.11876592965066
PubMed Web of Science ®Google Scholar
BonsignoriMAnalysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestorsJ. Virol.20118599981000910.1128/JVI.05045-113196428
PubMed Web of Science ®Google Scholar
BonsignoriMTwo distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine designJ. Virol.2012864688469210.1128/JVI.07163-113318651
PubMed Web of Science ®Google Scholar
BuchacherAGeneration of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalizationAIDS Res. Hum. Retrovir.19941035936910.1089/aid.1994.10.359
PubMed Web of Science ®Google Scholar
CrawfordJMCharacterization of primary isolate-like variants of simian-human immunodeficiency virusJ. Virol.1999731019910207113073
PubMed Web of Science ®Google Scholar
Etemad-MoghadamBDeterminants of neutralization resistance in the envelope glycoproteins of a simian-human immunodeficiency virus passaged in vivoJ. Virol.19997388738879112913
PubMed Web of Science ®Google Scholar
MascolaJRProtection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodiesJ. Virol.19997340094018104180
PubMed Web of Science ®Google Scholar
TrkolaAHuman monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1J. Virol.19967011001108189917
PubMed Web of Science ®Google Scholar
PurtscherMRestricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5AIDS19961058759310.1097/00002030-199606000-00003
PubMed Web of Science ®Google Scholar
PurtscherMA broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1AIDS Res. Hum. Retrovir.1994101651165810.1089/aid.1994.10.1651
PubMed Web of Science ®Google Scholar
StieglerGA potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1AIDS Res. Hum. Retrovir.2001171757176510.1089/08892220152741450
PubMed Web of Science ®Google Scholar
HuangJBroad and potent neutralization of HIV-1 by a gp41-specific human antibodyNature201249140641210.1038/nature115444854285
PubMed Web of Science ®Google Scholar
PlattEJBilskaMKozakSLKabatDMontefioriDCEvidence that ecotropic murine leukemia virus contamination in TZM-bl cells does not affect the outcome of neutralizing antibody assays with human immunodeficiency virus type 1J. Virol.2009838289829210.1128/JVI.00709-092715758
PubMed Web of Science ®Google Scholar
TakeuchiYMcClureMOPizzatoMIdentification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus researchJ. Virol.200882125851258810.1128/JVI.01726-082593302
PubMed Web of Science ®Google Scholar
DerdeynCASensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120J. Virol.2000748358836710.1128/JVI.74.18.8358-8367.2000116346
PubMed Web of Science ®Google Scholar
PlattEJWehrlyKKuhmannSEChesebroBKabatDEffects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1J. Virol.19987228552864109730
PubMed Web of Science ®Google Scholar
WeiXEmergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapyAntimicrob. Agents Chemother.2002461896190510.1128/AAC.46.6.1896-1905.2002127242
PubMed Web of Science ®Google Scholar
WeiXAntibody neutralization and escape by HIV-1Nature200342230731210.1038/nature01470
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Comparison of the genotypic and phenotypic properties of HIV-1 standard subtype B and subtype B/B′ env molecular clones derived from infections in China

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Comparison of the genotypic and phenotypic properties of HIV-1 standard subtype B and subtype B/B′ env molecular clones derived from infections in China

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date